Aripiprazole (Abilify) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
Phase of Trial: Phase IV
Latest Information Update: 10 Apr 2019
At a glance
- Drugs Aripiprazole (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 08 Apr 2019 Status changed from recruiting to completed.
- 06 Sep 2018 Planned End Date changed from 1 Jun 2016 to 1 Mar 2019.
- 06 Sep 2018 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2019.